PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1342
https://www.valueinhealthjournal.com/article/S1098-3015(11)02904-4/fulltext
Section Title :
Diabetes/Endocrine Disorders
Section Order :
1293
First Page :
A478
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02904-4&doi=10.1016/j.jval.2011.08.1342